These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19447025)

  • 1. A heroin prescription trial: case studies from Montreal and Vancouver on crime and disorder in the surrounding neighbourhoods.
    Lasnier B; Brochu S; Boyd N; Fischer B
    Int J Drug Policy; 2010 Jan; 21(1):28-35. PubMed ID: 19447025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of motivational status on treatment outcome in the North American Opiate Medication Initiative (NAOMI) study.
    Nosyk B; Geller J; Guh DP; Oviedo-Joekes E; Brissette S; Marsh DC; Schechter MT; Anis AH
    Drug Alcohol Depend; 2010 Sep; 111(1-2):161-5. PubMed ID: 20510549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telling our stories: heroin-assisted treatment and SNAP activism in the Downtown Eastside of Vancouver.
    Boyd S; Murray D; ; MacPherson D
    Harm Reduct J; 2017 May; 14(1):27. PubMed ID: 28521781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a sustained heroin shortage in three Australian States.
    Degenhardt L; Day C; Dietze P; Pointer S; Conroy E; Collins L; Hall W
    Addiction; 2005 Jul; 100(7):908-20. PubMed ID: 15954999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The current status of heroin prescription treatment for heroin dependence.
    Wodak A
    Expert Opin Drug Saf; 2005 Sep; 4(5):815-9. PubMed ID: 16111445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of acquisitive crime during methadone maintenance treatment among patients eligible for heroin assisted treatment.
    van der Zanden BP; Dijkgraaf MG; Blanken P; van Ree JM; van den Brink W
    Drug Alcohol Depend; 2007 Jan; 86(1):84-90. PubMed ID: 16806740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yet they failed to do so: recommendations based on the experiences of NAOMI research survivors and a call for action.
    Boyd S; Naomi Patients Association
    Harm Reduct J; 2013 Apr; 10():6. PubMed ID: 23594923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Andalusian trial on heroin-assisted treatment: a 2 year follow-up.
    Oviedo-Joekes E; March JC; Romero M; Perea-Milla E
    Drug Alcohol Rev; 2010 Jan; 29(1):75-80. PubMed ID: 20078686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does heroin-assisted treatment reduce crime? A review of randomized-controlled trials.
    Smart R; Reuter P
    Addiction; 2022 Mar; 117(3):518-531. PubMed ID: 34105206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
    Teesson M; Ross J; Darke S; Lynskey M; Ali R; Ritter A; Cooke R
    Drug Alcohol Depend; 2006 Jun; 83(2):174-80. PubMed ID: 16343809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy diacetylmorphine (pharmaceutical heroin) for heroin treatment ].
    Demaret I; Lemaître A; Ansseau M
    Rev Med Liege; 2010 Dec; 65(12):681-7. PubMed ID: 21287763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled trial of prescribed heroin in the treatment of opioid addiction.
    March JC; Oviedo-Joekes E; Perea-Milla E; Carrasco F;
    J Subst Abuse Treat; 2006 Sep; 31(2):203-11. PubMed ID: 16919749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of heroin-assisted treatment on alcohol consumption: findings of the German randomized controlled trial.
    Haasen C; Eiroa-Orosa FJ; Verthein U; Soyka M; Dilg C; Schäfer I; Reimer J
    Alcohol; 2009 Jun; 43(4):259-64. PubMed ID: 19375884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Explaining the effectiveness of heroin-assisted treatment on crime reductions.
    Löbmann R; Verthein U
    Law Hum Behav; 2009 Feb; 33(1):83-95. PubMed ID: 18594954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heroin-assisted treatment in the Netherlands: History, findings, and international context.
    Blanken P; van den Brink W; Hendriks VM; Huijsman IA; Klous MG; Rook EJ; Wakelin JS; Barendrecht C; Beijnen JH; van Ree JM
    Eur Neuropsychopharmacol; 2010 Apr; 20 Suppl 2():S105-58. PubMed ID: 20362236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Canadian heroin supply coinciding with the Australian heroin shortage.
    Wood E; Stoltz JA; Li K; Montaner JS; Kerr T
    Addiction; 2006 May; 101(5):689-95. PubMed ID: 16669902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS).
    Ross J; Teesson M; Darke S; Lynskey M; Ali R; Ritter A; Cooke R
    Drug Alcohol Rev; 2005 Sep; 24(5):411-8. PubMed ID: 16298835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-threshold methadone treatment, heroin price, police activity and incidence of heroin use: the Zurich experience.
    Nordt C; Stohler R
    Int J Drug Policy; 2009 Nov; 20(6):497-501. PubMed ID: 19349154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of illicit drug supply reduction on health and social outcomes: the heroin shortage in the Australian Capital Territory.
    Smithson M; McFadden M; Mwesigye SE; Casey T
    Addiction; 2004 Mar; 99(3):340-8. PubMed ID: 14982547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The impact of opening a heroin-assisted treatment clinic on the surrounding neighborhood].
    Ally MA; Brochu S; Blais E
    Can J Public Health; 2011; 102(3):183-7. PubMed ID: 21717665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.